BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170306
DTEND;VALUE=DATE:20170308
DTSTAMP:20260731T104548
CREATED:20160907T200112Z
LAST-MODIFIED:20160907T202217Z
UID:17388-1488758400-1488931199@ces.b2sg.org
SUMMARY:Epigenetics in Drug Discovery
DESCRIPTION:SELECTBIO is thrilled to announce the continuation of Epigenetics in Drug Discovery for 2017. \nThe event will form part of the multi-track conference\, Advances in Drug Discovery\, and will run alongside three additional tracks: Antibodies in Drug Discovery\, Academic Drug Discovery and Stem Cells in Drug Discovery. \nAs a multi-track event\, delegates will have unrestricted access to all conference tracks and networking opportunities. Attracting researchers from both academia and industry\, this track will explore the latest opportunities and challenges for epigeneticists looking to discover and develop new molecular entities. Topics to be addressed include\, assays for Methyltranferases and Demethylases\, Bromodomain inhibitor discovery\, indications beyond cancer\, Non-BET Bromodomains and of course updates in Oncology. \nThanks to vast steps forwards in this field\, epigenetic compounds are becoming more and more common in both pre-clinical and clinical drug discovery. If you work in epigenetics research\, you will benefit from the expert knowledge of academic and industry leaders who are pushing the boundaries of drug discovery\, whilst networking with the technology providers who are enabling them to do so. \nThe Cancer Epigenetics Society is a Supporting organization for this meeting\, and our members are eligible for a 20% discount on registration fees. Please contact the Cancer Epigenetics Society at info@ces.b2sg.org to claim the discount.
URL:https://ces.b2sg.org/event/epigenetics-in-drug-discovery/
LOCATION:Epigenetics in Drug Discovery\, Wellcome Genome Campus Conference Centre\, Hinxton\, Cambridge\, CB10 1RQ\, United Kingdom
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/09/SelectBio_logo_greybox_RGB.png
ORGANIZER;CN="SELECTBIO":MAILTO:registrationhelp@selectbio.com
END:VEVENT
END:VCALENDAR